Clinical Trial

Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 5, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
assess whether there is a correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma. Identification of reliable prognostic factors could help to identify high-risk patients, which may require a different treatment and follow up.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-29; most recent amendment 2025-03-04.
Trial Details
NCT Number NCT06243588
Lead Sponsor Istituto Ortopedico Rizzoli
Conditions Ewing Sarcoma
Enrollment 400 participants
Start Date 2024-01-25
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-05